CST7 and Alzheimer disease: A key finding of our study was that high levels of microglial CST7 could be implicated in the depressive-like behavior associated with AD, and that TSA could attenuate neuropsychiatric disorders in AD by inhibiting microglial inflammatory response linked to CST7. However, the underlying molecular mechanisms of TSA on inhibiting CST7 expression also need to be further explored.